Agilent Technologies, Inc. A1GI34.SA Stock
Agilent Technologies, Inc. Price Chart
Agilent Technologies, Inc. A1GI34.SA Financial and Trading Overview
Agilent Technologies, Inc. stock price | 328.4 BRL |
Previous Close | 291.36 BRL |
Open | 0 BRL |
Bid | 290.86 BRL x N/A |
Ask | 295.83 BRL x N/A |
Day's Range | 0 - 0 BRL |
52 Week Range | 0 - 408.36 BRL |
Volume | 0 BRL |
Avg. Volume | 0 BRL |
Market Cap | 174.44B BRL |
Beta (5Y Monthly) | 1.044014 |
PE Ratio (TTM) | 26.804047 |
EPS (TTM) | 10.64 BRL |
Forward Dividend & Yield | 2.25 (0.77%) |
Ex-Dividend Date | January 2, 2023 |
1y Target Est | N/A |
A1GI34.SA Valuation Measures
Enterprise Value | 173.84B BRL |
Trailing P/E | 26.804047 |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 24.77818 |
Price/Book (mrq) | 29.762499 |
Enterprise Value/Revenue | 24.693 |
Enterprise Value/EBITDA | 84.428 |
Trading Information
Agilent Technologies, Inc. Stock Price History
Beta (5Y Monthly) | 1.044014 |
52-Week Change | -1.099% |
S&P500 52-Week Change | 20.43% |
52 Week High | 408.36 BRL |
52 Week Low | 0 BRL |
50-Day Moving Average | 368.8 BRL |
200-Day Moving Average | 374.18 BRL |
A1GI34.SA Share Statistics
Avg. Volume (3 month) | 0 BRL |
Avg. Daily Volume (10-Days) | 2 BRL |
Shares Outstanding | 590.75M |
Float | 588.84M |
Short Ratio | N/A |
% Held by Insiders | 0% |
% Held by Institutions | 0% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0.87 |
Trailing Annual Dividend Yield | 0.29% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0.1418 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | October 31, 2022 |
Most Recent Quarter (mrq) | April 30, 2023 |
Next Fiscal Year End | October 31, 2023 |
Profitability
Profit Margin | 19.18% |
Operating Margin (ttm) | 25.11% |
Gross Margin | 54.58% |
EBITDA Margin | 29.24% |
Management Effectiveness
Return on Assets (ttm) | 10.40% |
Return on Equity (ttm) | 24.78% |
Income Statement
Revenue (ttm) | 7.04B BRL |
Revenue Per Share (ttm) | 11.85 BRL |
Quarterly Revenue Growth (yoy) | 6.80% |
Gross Profit (ttm) | 3.72B BRL |
EBITDA | 2.06B BRL |
Net Income Avi to Common (ttm) | 1.35B BRL |
Diluted EPS (ttm) | 10.87 |
Quarterly Earnings Growth (yoy) | 10.19% |
Balance Sheet
Total Cash (mrq) | 1.18B BRL |
Total Cash Per Share (mrq) | 1.99 BRL |
Total Debt (mrq) | 2.89B BRL |
Total Debt/Equity (mrq) | 50.01 BRL |
Current Ratio (mrq) | 2.37 |
Book Value Per Share (mrq) | 9.7895 |
Cash Flow Statement
Operating Cash Flow (ttm) | 1.47B BRL |
Levered Free Cash Flow (ttm) | 867.12M BRL |
Profile of Agilent Technologies, Inc.
Country | Brazil |
State | CA |
City | Santa Clara |
Address | 5301 Stevens Creek Boulevard |
ZIP | 95051 |
Phone | 800 227 9770 |
Website | https://www.agilent.com |
Industry | Diagnostics & Research |
Sector(s) | Healthcare |
Full Time Employees | 18400 |
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps, and measurement technologies. The Diagnostics and Genomics segment provides arrays for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, gene expression profiling, next generation sequencing, target enrichment and genetic data management, and interpretation support software; and produces synthesized oligonucleotide. It also offers immunohistochemistry in situ hybridization, and hematoxylin and eosin staining and special staining; consumables, and software for quality control analysis of nucleic acid samples; and reagents for use in turbidimetry and flow cytometry, as well as develops liquid-based pharmacodiagnostics. The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and startup, operational, training, compliance support, software as a service, asset management, and consultation services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.
Q&A For Agilent Technologies, Inc. Stock
What is a current A1GI34.SA stock price?
Agilent Technologies, Inc. A1GI34.SA stock price today per share is 328.4 BRL.
How to purchase Agilent Technologies, Inc. stock?
You can buy A1GI34.SA shares on the São Paulo exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Agilent Technologies, Inc.?
The stock symbol or ticker of Agilent Technologies, Inc. is A1GI34.SA.
Which industry does the Agilent Technologies, Inc. company belong to?
The Agilent Technologies, Inc. industry is Diagnostics & Research.
How many shares does Agilent Technologies, Inc. have in circulation?
The max supply of Agilent Technologies, Inc. shares is 639.65M.
What is Agilent Technologies, Inc. Price to Earnings Ratio (PE Ratio)?
Agilent Technologies, Inc. PE Ratio is 30.86466000 now.
What was Agilent Technologies, Inc. earnings per share over the trailing 12 months (TTM)?
Agilent Technologies, Inc. EPS is 10.64 BRL over the trailing 12 months.
Which sector does the Agilent Technologies, Inc. company belong to?
The Agilent Technologies, Inc. sector is Healthcare.